Detection of malarial DNA in blood donors - evidence of persistent infection

Vox Sanguinis

Volumn 107, Issue 2, 2014, Pages 123-131

  Kitchen, A D ^a   Chiodini, P L ^b,c   Tossell, J ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Malaria risk; Malarial DNA; Malarial serology; Parasitaemia

Indexed keywords

PARASITE ANTIGEN; PROTOZOAL DNA; PROTOZOON ANTIBODY;

ADULT; BLOOD; BLOOD DONOR; BLOOD SAFETY; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; MALARIA; MALE; PARASITEMIA; PLASMODIUM; YOUNG ADULT;

ADULT; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BLOOD DONORS; BLOOD SAFETY; DNA, PROTOZOAN; FEMALE; HUMANS; MALARIA; MALE; PARASITEMIA; PLASMODIUM; YOUNG ADULT;

EID: 84904417106     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12142     Document Type: Article

References (18)

1. Kitchen AD, Barbara JA, Hewitt PE: Documented cases of post-transfusion malaria occurring in England: a review in relation to current and proposed donor selection guidelines. Vox Sang 2005; 89:77-80
2. Guidelines for Blood Transfusion Services in the UK; 8th Edition, 2013. Available at: http://www.transfusionguidelines.org.uk/index.aspx?Publication=RB&Section=25 (Last accessed 14 January 2014)
3. Bass C, Nikou D, Blagborough AM, et al.: PCR-based detection of Plasmodium in Anopheles mosquitoes: a comparison of a new high-throughput assay with existing methods. Malar J 2008; 7:177
4. Kitchen AD, Lowe PHJ, Lalloo K, et al.: Evaluation of a malarial antibody screening assay for use in the screening of blood and tissue products for clinical use. Vox Sang 2004; 87:150-155
5. Leiby DA, Nguyen ML, Notari EP: Impact of donor deferrals for malaria on blood availability in the United States. Transfusion 2008; 48:2222-2228
6. Seed CR, Kee G, Wong T, et al.: Assessing the safety and efficacy of a test-based, targeted donor screening strategy to minimise transfusion transmitted malaria. Vox Sang 2010; 98:e182-e192
7. Garraud O, Assal A, Pelletier B, et al.: Overview of revised measures to prevent malaria transmission by blood transfusion in France. Vox Sang 2008; 95:226-231
8. Reesink HW, Panzer S, Wendel S, et al.: The use of malaria antibody tests in the prevention of transfusion-transmitted malaria. Vox Sang 2010; 98:468-478
9. Serious Hazards of Transfusion Annual Report 2012. Available at: http://www.shotuk.org/shot-reports/report-summary-and-supplement-2012/ (Last accessed 14 January 2014)
10. Grande R, Petrini G, Silvani I, et al.: Immunological testing for malaria and blood donor deferral: the experience of the Ca' Granda Polyclinic Hospital in Milan. Blood Transfus 2011; 9:162-166
11. Contreras CE, Donato MD, Rivas MA, et al.: Malaria seroprevalence in blood bank donors from endemic and non-endemic areas of Venezuela. Mem Inst Oswaldo Cruz 2011; 106:123-9
12. Sobani ZA, Nizami S, Jabeen M, et al.: Reducing transfusion-associated malaria in Pakistan: an algorithmic approach. Trop Doct 2013; 43:124-127
13. Vinetz JM, Li J, McCutchan TF, et al.: Plasmodium malariae infection in an asymptomatic 74-year-old Greek woman with splenomegaly. N Engl J Med 1998; 338:367-371
14. Molineaux L, Diebner HH, Eichner M, et al.: Plasmodium falciparum parasitaemia described by a new mathematical model. Parasitology 2001; 122:379-391
15. D'Ortenzio E, Godineau N, Fontanet A, et al.: Prolonged Plasmodium falciparum infection in immigrants, Paris. Emerg Infect Dis 2008; 14:323-326
16. Theunissen C, Janssens P, Demulder A, et al.: Falciparum malaria in patient 9 years after leaving malaria-endemic area. Emerg Infect Dis 2009; 15:115-116
17. Howden BP, Vaddadi G, Manitta J, et al.: Chronic falciparum malaria causing massive splenomegaly 9 years after leaving an endemic area. Med J Aust 2005; 182:186-188
18. Cryptic Malaria Guidance 2011. Available at: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1287146147988. (Last accessed 29 January 2014)